We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+15.92%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$384M
AUM Growth
+$106M
Cap. Flow
+$85.6M
Cap. Flow %
22.32%
Top 10 Hldgs %
38.06%
Holding
80
New
28
Increased
20
Reduced
13
Closed
19

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$13.1M
2
CVS icon
CVS Health
CVS
+$12.2M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$10.6M
4
IVC
Invacare Corporation
IVC
+$10.3M
5
KIDS icon
OrthoPediatrics
KIDS
+$9.75M

Top Sells

Rank Stock Value
1
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
+$39.1M
2
ACRS icon
Aclaris Therapeutics
ACRS
+$13.1M
3
SIBN icon
SI-BONE Inc
SIBN
+$7.62M
4
SNN icon
Smith & Nephew
SNN
+$7.55M
5
CI icon
Cigna
CI
+$5.22M

Sector Composition

Rank Sector Weight
1 Healthcare 85.83%
2 Industrials 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QTNT
76
DELISTED
Quotient Limited Ordinary Shares
QTNT
– –
-5,665
Closed -$1.18M
PRAH
77
DELISTED
PRA Health Sciences, Inc.
PRAH
– –
-21,590
Closed -$2.71M
OXFD
78
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
– –
-2,240,421
Closed -$39.1M
1 2 3
4

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Endurant Capital Management held 80 positions worth $384M, up 38% from $277M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Endurant Capital Management deployed $85.6M of net new capital in Q1 2021, opening 28 new positions and adding to 20 existing holdings. Its largest new stake was Sanofi: 272,218 shares worth $13.5M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 94% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Aclaris Therapeutics, an estimated $13.1M trimmed.

  • Endurant Capital Management's largest Q1 2021 buy was Sanofi: 272,218 shares worth $13.5M.
  • Endurant Capital Management added most to Iovance Biotherapeutics in Q1 2021, an estimated $10.6M increase.
  • Endurant Capital Management's biggest Q1 2021 reduction was Aclaris Therapeutics, cutting an estimated $13.1M.
  • Endurant Capital Management fully exited Oxford Immunotec Global PLC Ordinary Shares in Q1 2021, selling an estimated $39.1M.
  • Endurant Capital Management's ten largest holdings make up 38% of its $384M portfolio in Q1 2021.
  • Endurant Capital Management opened 28 new positions and closed 19 in Q1 2021.
  • Endurant Capital Management's portfolio value rose 38% quarter-over-quarter to $384M.

Based on Endurant Capital Management's 13F filing for Q1 2021, filed 17 May 2021.